- KR₩171bn
- KR₩167bn
- KR₩16bn
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 5.66 | ||
Price to Tang. Book | 8.34 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 8.82 | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -9.95% | ||
Return on Equity | -19.08% | ||
Operating Margin | -18.77% |
Financial Summary
Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | KR₩m | 9,287.49 | 6,357.11 | 13,625.37 | 21,670.44 | 15,703.95 | n/a | n/a | 24.7% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
NIBEC Co., Ltd. is a Korea-based company specialized in the manufacturing of dental medical products and supplies. The Company provides two main categories of products: dental health products and regeneration biomaterials. The dental health products consist of tooth whitening products under the brand name Blanc Tis; remedies for sensitive teeth under the brand name SensBlok, and dental conditioners under the brand name Clinplant. The regeneration biomaterials include bone graft materials under the brand name OCS-B, OCS-H and OCS-Collagen, as well as bone regenerative powders, bone morphogenetic materials, peptide bone powders and injectable gels. It also provides cosmetics under the brand name Skin Aropa. The Company distributes its products within domestic market and to overseas markets.
Directors
- Jong Pyeong Jung CEO (67)
- Yun Jeong Park MDR (42)
- Yang Jo Sul OTH (45)
- Ju Yeon Lee DRC (38)
- Sa Seong Kim NID (47)
- Last Annual
- December 31st, 2023
- Last Interim
- June 30th, 2024
- Incorporated
- February 20th, 2004
- Public Since
- July 13th, 2011
- No. of Shareholders
- 13,207
- No. of Employees
- 87
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- Korea Exchange - KOSDAQ
- Shares in Issue
- 10,291,823
- Address
- 116, Bamdi-gil, Iwol-myeon, JINCHEON, 27816
- Web
- https://nibec.co.kr/
- Phone
- +82 435327458
- Auditors
- Samil Accounting Corp.
Upcoming Events for 138610
Similar to 138610
ABion
Korea Exchange - KOSDAQ
ABL Bio
Korea Exchange - KOSDAQ
Amicogen
Korea Exchange - KOSDAQ
AprilBio Co
Korea Exchange - KOSDAQ
AptaBio Therapeutics
Korea Exchange - KOSDAQ
FAQ
As of Today at 22:17 UTC, shares in Nibec Co are trading at KR₩16,640. This share price information is delayed by 15 minutes.
Shares in Nibec Co last closed at KR₩16,640 and the price had moved by -19.47% over the past 365 days. In terms of relative price strength the Nibec Co share price has underperformed the FTSE Developed Asia Pacific Index by -31.23% over the past year.
There is no consensus recommendation for this security.
Find out moreNibec Co does not currently pay a dividend.
Nibec Co does not currently pay a dividend.
Nibec Co does not currently pay a dividend.
To buy shares in Nibec Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of KR₩16,640, shares in Nibec Co had a market capitalisation of KR₩171bn.
Here are the trading details for Nibec Co:
- Country of listing: Korea, Republic of
- Exchange: KOE
- Ticker Symbol: 138610
Based on an overall assessment of its quality, value and momentum Nibec Co is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Nibec Co. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -14.17%.
As of the last closing price of KR₩16,640, shares in Nibec Co were trading -8.59% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Nibec Co PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at KR₩16,640.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Nibec Co's management team is headed by:
- Jong Pyeong Jung - CEO
- Yun Jeong Park - MDR
- Yang Jo Sul - OTH
- Ju Yeon Lee - DRC
- Sa Seong Kim - NID